Centre de Recherche en Rhumatologie et Immunologie, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC, Canada.
Mol Immunol. 2010 Feb;47(5):991-9. doi: 10.1016/j.molimm.2009.11.020. Epub 2009 Dec 21.
Previous studies showed that P2 receptors are involved in neutrophil migration via stimulation of chemokine release and by facilitating chemoattractant gradient sensing. Here, we have investigated whether these receptors are involved in LPS-induced neutrophil transendothelial migration (TEM) using a Boyden chamber where neutrophils migrated through a layer of lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVECs). In line with a role of P2 receptors, neutrophil TEM was inhibited by the P2 receptor antagonists suramin and reactive blue 2 (RB-2) acting on the basolateral, but not luminal, HUVECs' P2 receptors. HUVECs express P2Y(1), P2Y(2), P2Y(4), P2Y(6) and P2Y(11). The involvement of P2Y(4) was unlikely as this receptor is insensitive to suramin while P2Y(1), P2Y(6) and P2Y(11) were excluded with available selective antagonists, leaving P2Y(2) as the only candidate. Indeed, the P2Y(2) knockdown in HUVECs inhibited neutrophil TEM compared to control HUVECs transfected with scrambled siRNA. Moreover, UTP, a P2Y(2) ligand, markedly potentiated LPS-induced TEM. Interestingly, IL-8 and ICAM-1 had a modest effect on neutrophil TEM in this 3h assay which was significantly diminished by the inhibition of Rho kinase in HUVECs with Y27632. In summary, endothelial P2Y(2) receptors control the early LPS-induced neutrophil TEM in vitro via Rho kinase activation.
先前的研究表明,P2 受体通过刺激趋化因子释放和促进趋化因子梯度感应,参与中性粒细胞迁移。在这里,我们通过 Boyden 室研究了这些受体是否参与了 LPS 诱导的中性粒细胞跨内皮迁移(TEM),其中中性粒细胞通过一层 LPS 刺激的人脐静脉内皮细胞(HUVEC)迁移。与 P2 受体的作用一致,P2 受体拮抗剂苏拉明和反应蓝 2(RB-2)作用于基底外侧而非腔侧的 HUVECs P2 受体,抑制了中性粒细胞 TEM。HUVECs 表达 P2Y(1)、P2Y(2)、P2Y(4)、P2Y(6)和 P2Y(11)。由于这种受体对苏拉明不敏感,因此 P2Y(4)受体不太可能参与其中,而可用的选择性拮抗剂排除了 P2Y(1)、P2Y(6)和 P2Y(11),只剩下 P2Y(2)作为唯一的候选受体。事实上,与转染 scrambled siRNA 的对照 HUVEC 相比,HUVEC 中的 P2Y(2)敲低抑制了中性粒细胞 TEM。此外,UTP,一种 P2Y(2)配体,显著增强了 LPS 诱导的 TEM。有趣的是,在这个 3h 测定中,IL-8 和 ICAM-1 对中性粒细胞 TEM 仅有适度影响,而 Y27632 抑制 HUVEC 中的 Rho 激酶后,这种影响显著减弱。总之,内皮 P2Y(2)受体通过 Rho 激酶激活控制体外早期 LPS 诱导的中性粒细胞 TEM。